Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats

doi:10.3748/wjg.v10.i6.813

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3026)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

355

HTML

2399

Figures (1-4)

151

Tables (1-4)

121

Sum=3026

Mar 15, 2004 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Mar 15, 2004; 10(6): 813-818
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.813

Full Size Figure Download Figure

Figure 2 RT-PCR analysis of VEGF mRNA level in cancerous and peri-cancerous tissues using G₃PDH as internal control. Control group: 1 tumor, 2 peri-tumor. LP group: 3 tumor, 4 peri-tumor. LP+ODNs group: 5 tumor, 6 peri-tumor, 7 marker.

Citation: Wu HP, Feng GS, Liang HM, Zheng CS, Li X. Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats. World J Gastroenterol 2004; 10(6): 813-818
URL: https://www.wjgnet.com/1007-9327/full/v10/i6/813.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i6.813